From: Site-specific analysis of gene expression in early osteoarthritis using the Pond-Nuki model in dogs
p value | ACL-X | Control | CrMTP | CrLTP | ACL-X | Control | p value |
---|---|---|---|---|---|---|---|
<0.05 | 0.093 ± 0.02 | 0.018 ± 0.018 | MMP 13 | COL 1 | 5.46 ± 3.96 | 0.48 ± 0.08 | <0.05 |
 |  |  |  | COL 2 | 1022 ± 651 | 254 ± 84 | <0.05 |
 |  |  |  | MMP 13 | 0.147 ± 0.012 | 0 ± 0 | <0.05 |
 |  |  |  | INOS | 0.362 ± 0.065 | 0.04 ± 0.04 | <0.05 |
 |  |  |  | COX-2 | 0.007 ± 0.005 | 0 ± 0 | <0.05 |
 |  |  |  | TIMP-1 | 35.3 ± 4.6 | 8.4 ± 5.4 | <0.05 |
 |  |  |  | MMP 3 | 2.428 ± 1.272 | 0.587 ± 0.18 | <0.05 |
 |  |  |  | ADAMTS 5 | 0.132 ± 0.05 | 0.024 ± 0.024 | <0.05 |
p value | ACL-X | Control | CaMTP | CaLTP | ACL-X | Control | p value |
<0.05 | 378.6 ± 321.42 | 9.05 ± 7.08 | COL 1 | COL 1 | 78.85 ± 43.79 | 1.98 ± 1.72 | <0.05 |
<0.05 | 2787 ± 1919 | 594 ± 151 | COL 2 | COL 2 | 1926 ± 939 | 708 ± 49 | <0.05 |
<0.05 | 0.074 ± 0.059 | 0.007 ± 0.007 | MMP 13 | MMP 13 | 0.05 ± 0.002 | 0.011 ± 0.011 | <0.05 |
<0.05 | 0.051 ± 0.044 | 0.003 ± 0.001 | COX-2 | COX-2 | 0.019 ± 0.006 | 0.002 ± 0.002 | <0.05 |
<0.05 | 0.189 ± 0.019 | 0.088 ± 0.002 | INOS |  |  |  |  |
<0.05 | 0.023 ± 0.011 | 0.002 ± 0.002 | ADAMTS 5 |  |  |  |  |
<0.05 | 1.4 ± 0.07 | 3.71 ± 0.08 | TIMP-2 | TIMP-2 | 0.99 ± 0.02 | 2.7 ± 0.8 | <0.05 |